Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
about
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancerThe ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancerPromoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancerDual role of macrophage migration inhibitory factor (MIF) in human breast cancerFrequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysisPromoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancerPrognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysisBDNF is associated with SFRP1 expression in luminal and basal-like breast cancer cell lines and primary breast cancer tissues: a novel role in tumor suppression?Overexpression of Kpnβ1 and Kpnα2 importin proteins in cancer derives from deregulated E2F activityIdentifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression dataNuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosisTight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.Quantitative RT-PCR gene expression analysis of laser microdissected tissue samplesProduction and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer.Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.Karyopherin alpha 2 expression is a novel diagnostic and prognostic factor for colorectal cancerInfinite mixture-of-experts model for sparse survival regression with application to breast cancer.Targeting nucleocytoplasmic transport in cancer therapyOverexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis.AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.Diversification of importin-α isoforms in cellular trafficking and disease statesHigh expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.Targeting nuclear transporters in cancer: Diagnostic, prognostic and therapeutic potential.Nuclear importin α and its physiological importanceAbundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast CancerKPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancerDevelopment of a pipeline for automated, high-throughput analysis of paraspeckle proteins reveals specific roles for importin α proteins.Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancerDexamethasone sensitizes the neonatal intestine to fructose induction of intestinal fructose transporter (Slc2A5) function.Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome.Nuclear size is sensitive to NTF2 protein levels in a manner dependent on Ran bindingMIR517C inhibits autophagy and the epithelial-to-mesenchymal (-like) transition phenotype in human glioblastoma through KPNA2-dependent disruption of TP53 nuclear translocationKPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cellsDownregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expressionGene expression abnormalities in histologically normal breast epithelium from patients with luminal type of breast cancer.
P2860
Q21195213-B8F8842E-0221-4AA4-845D-34EDDE47F273Q21195217-F2D03A21-2812-4A1A-862E-8FCAEDDAD2FAQ21245721-BFC9256F-7090-48AF-B17F-BAD98A9D9222Q21260384-944025E2-D202-40BE-BF48-95F29E228438Q21260401-B114673C-9036-4535-A8B4-69EF5149A6AFQ24652213-6966870D-B00B-4378-8593-8585496D7592Q28071479-0C31DFEC-29E5-456F-97BC-56C4486252A2Q28540922-71A866F1-B9A3-4292-B195-56ECE40DFAA4Q28742539-7FD0E8BB-832A-46AE-AC52-9F661BB0889DQ30587051-58CBA45D-EDCC-43F5-B40D-D0AC5EFEA68CQ30908486-3F23A096-2337-4080-BBDE-2374640A7EA5Q31108673-2F69752D-78AC-43CE-B74A-848F30D101CDQ33318574-5DD3B8B4-C8FD-4DFB-BFEF-CFD29C906C22Q33367810-C9F5A7C0-CED9-412B-A9C0-246877C6FAE1Q33455428-FFB08BD4-CF42-48C7-8751-BD8FC81D09A4Q33474183-0CC8A288-9631-4EC1-8BCC-0C2C811131E7Q33496580-49FD863A-BF48-4AA3-89E1-192BC33A5690Q33598264-9A5DB270-E9EE-4CEC-9024-1EFFC9E42F3BQ33733618-5D5BA12D-0CEC-41D8-9AD8-C1E693E0C7DBQ34398166-866550A4-04DD-4F5D-B0D0-442A15C9B74CQ34409715-CAAD3288-BBEE-430A-99B7-07EAE6DC92E4Q35432936-EA3DD0FF-5692-4EA3-AE93-CEA864E290A0Q35511186-C0A27F15-EDD8-4C5A-9AD5-0F1A9A564B75Q35609624-44F624AC-FEFE-4068-89F2-D10CB1E8D4A1Q35955008-F015DADD-C89D-47A0-A56E-9664A45BDCACQ36034989-646DAAF7-6C13-488A-AA1F-82F50C6F255DQ36072730-3752C475-F9EB-467A-B616-C839203C4FFAQ36086823-EC5CADC4-980A-4CFB-9CDF-A4DD563A72BAQ36291283-75F5EB24-E917-41B8-89C1-69734D3EFB12Q36336250-0BFB55F7-2B0C-4440-8A74-07CAC454F557Q36372601-5CB521FA-264F-47FF-A4BE-821E0CCC33B9Q36386895-F9E4BE68-04FD-4E52-94F6-55B996ECDF75Q36414297-AB77D933-F5DD-4ACC-B6BD-E058DA81F5C4Q36511735-2B7C1181-0574-414F-BF5D-874856ACFC14Q36743893-E15C339D-A925-4C37-A870-2C1DB6096C7BQ36808390-E679943C-DE47-4E70-B266-00D385D5FB14Q37148209-20B36BD8-A6C0-406D-9C36-B4F46979CD0BQ37295372-0EC60754-BC60-4B4B-96DC-4BFA8EE4D051Q37360952-A7BB8F36-43A4-40E6-9CB0-17C2AD9CD7D5Q38470401-7D41568F-EE06-48F0-B8CE-3760B6BF8B76
P2860
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular profiling of laser-m ...... ostic marker in breast cancer.
@ast
Molecular profiling of laser-m ...... ostic marker in breast cancer.
@en
type
label
Molecular profiling of laser-m ...... ostic marker in breast cancer.
@ast
Molecular profiling of laser-m ...... ostic marker in breast cancer.
@en
prefLabel
Molecular profiling of laser-m ...... ostic marker in breast cancer.
@ast
Molecular profiling of laser-m ...... ostic marker in breast cancer.
@en
P2093
P1476
Molecular profiling of laser-m ...... ostic marker in breast cancer.
@en
P2093
André Rosenthal
Arndt Hartmann
Bernd Hinzmann
Edgar Dahl
Elke Ebner
Glen Kristiansen
Hagen Blaszyk
Irina Klaman
Kathrin Gottlob
Klaus Hermann
P304
P356
10.1158/1078-0432.CCR-05-2090
P407
P577
2006-07-01T00:00:00Z